Literature DB >> 7562936

Synthesis of tight binding inhibitors and their action on the proprotein-processing enzyme furin.

H Angliker1.   

Abstract

Furin is a subtilisin-like eukaryotic serine endoprotease which processes proproteins to biologically active proteins and peptides. Also, the envelope proteins of viruses, such as influenza and HIV viruses, need to be processed by furin for infectivity. This enzyme has a consensus substrate specificity for Arg-Xxx-Lys/Arg-Arg at the cleavage site. Two kinds of transition state analog peptides were designed and tested in vitro with furin. The ketomethylene series, psi (COCH2), have Ki's in the submicromolar range; the aminomethyl aminomethyl ketone series, psi(COCH2NH), have Ki's in the nanomolar range. The best inhibitor is Dec-Arg-Val-Lys-Arg-CH2-Ala-Val-Gly-NH2 (2c) with a Ki of 3.4 nM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562936     DOI: 10.1021/jm00020a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

2.  Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6).

Authors:  Daniel E Bassi; Jonathan Cenna; Jirong Zhang; Edna Cukierman; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2014-05-21       Impact factor: 4.784

Review 3.  Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins.

Authors:  K Nakayama
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine.

Authors:  Guan-Sheng Jiao; Lynne Cregar; Jinzhi Wang; Sherri Z Millis; Cho Tang; Sean O'Malley; Alan T Johnson; Sina Sareth; Jason Larson; Gary Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-18       Impact factor: 11.205

5.  Stability of mutant serpin/furin complexes: dependence on pH and regulation at the deacylation step.

Authors:  Erick K Dufour; Antoine Désilets; Jean-Michel Longpré; Richard Leduc
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

6.  Furin inhibitor D6R suppresses epithelial-mesenchymal transition in SW1990 and PaTu8988 cells via the Hippo-YAP signaling pathway.

Authors:  Meng Zhou; Youli Zhang; Hong Wei; Junbo He; Dawei Wang; Baoding Chen; Jian Zeng; Aihua Gong; Min Xu
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

Review 7.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

8.  New furin inhibitors based on weakly basic amidinohydrazones.

Authors:  Frank Sielaff; Manuel E Than; Dorian Bevec; Iris Lindberg; Torsten Steinmetzer
Journal:  Bioorg Med Chem Lett       Date:  2010-11-25       Impact factor: 2.823

9.  Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition.

Authors:  Hiroyuki Yamamoto; Bruno Ramos-Molina; Adam N Lick; Matthew Prideaux; Valeria Albornoz; Lynda Bonewald; Iris Lindberg
Journal:  Bone       Date:  2015-12-31       Impact factor: 4.398

10.  A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C.

Authors:  Ajoy Basak; Abdel-Majid Khatib; Dayani Mohottalage; Sarmistha Basak; Maria Kolajova; Subhendu Sekhar Bag; Amit Basak
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.